Seeing Is Believing
Currently out of the existing stock ratings of Ryan Zimmerman, 197 are a BUY (91.2%), 17 are a HOLD (7.87%), 2 are a SELL (0.93%).
Analyst Ryan Zimmerman, currently employed at BTIG, carries an average stock price target met ratio of 56.48% that have a potential upside of 30.25% achieved within 169 days.
Ryan Zimmerman’s has documented 419 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 03-Oct-2024.
Analyst best performing recommendations are on ORGO (ORGANOGENESIS HOLDINGS).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 12/28/2022. The price target of $67 was fulfilled within 14 days with a profit of $20.18 (43.1%) receiving and performance score of 30.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$104
$6.73 (6.92%)
$98
23 days ago
9/10 (90%)
$3.24 (3.22%)
91
Buy
$110
$12.73 (13.09%)
$104
1 months 13 days ago
7/9 (77.78%)
$14.67 (15.39%)
282
Buy
$107
$9.73 (10.00%)
$101
1 months 13 days ago
14/19 (73.68%)
$11.67 (12.24%)
334
Buy
$105
$7.73 (7.95%)
$100
4 months 20 days ago
11/12 (91.67%)
$15.03 (16.71%)
311
Buy
$100
$2.73 (2.81%)
$90
7 months 1 days ago
6/6 (100%)
$13.26 (15.29%)
297
Which stock is Ryan Zimmerman is most bullish on?
Which stock is Ryan Zimmerman is most reserved on?
What Year was the first public recommendation made by Ryan Zimmerman?